T. Rowe Price Investment Management, Inc., a registered investment adviser, initiated a new position in UNITEDHEALTH GROUP INCORPORATED (Delaware) (NYSE:UNH) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 4,109,029 shares of the Healthcare company, valued at approximately $1.4B as of the filing date.
UNITEDHEALTH GROUP INCORPORATED (Delaware)'s stock currently trades at $280.61 with a market capitalization of $305.0B.
